OR WAIT null SECS
The Food and Drug Administration (FDA) and Congress have been focused on providing legislation for a solution to the mounting issues of recall with regard to surgical medical implants. Major medical device companies are being faced daily with escalating class action law suits, due to the lack of validated tracking controls with tracking of implants on a global basis.
iTraycers recent debut at the North American Spine Society (NASS) meeting in Orlando, Fla. offered the keys for control of the issues facing all medical implant companies today.
FDA classifies medical device recalls into three categories representing the potential risk to public health: Class I, Class II and Class III. This classification process usually takes place after the company has issued its recall.
"The recent launch at NASS was applauded by the major manufacturers as the total package needed to provide a complete solution to tracking medical implants on a global scale, ays iTraycer chairman and CEO Greg Smith. "Our new generation proprietary patent pending application was demonstrated and acknowledged as the front runner in providing a complete end-to-end solution to the issues surrounding the recall and tracking of surgical medical implants. We have witnessed an ever-growing demand for a solution and have stepped forward to meet this need."
iTraycer provides on-the-go mobility with a simple, easy-to-use interface. It works on all medical products regardless of conditions, including sterilization environments, and tray, device and biologic-level management.
iTraycer allows input of lot numbers automatically via gold standard EDI, or manually with a companion Barcode or RFID Reader. It also provides automatic FDA and device expiration alerts; a Case Scheduler; Loaner Manager; Case Manager; Revenue Tracker and Shipment Tracking. iTraycer provides hospitals, manufacturers, reps, and surgeons a fast accurate efficient solution to log/track and search for lot and part numbers within seconds.